Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Suminobu Ito"'
Autor:
Megumu K. Saito, Mitsujiro Osawa, Nao Tsuchida, Kotaro Shiraishi, Akira Niwa, Knut Woltjen, Isao Asaka, Katsuhisa Ogata, Suminobu Ito, Shuzo Kobayashi, Shinya Yamanaka
Publikováno v:
Inflammation and Regeneration, Vol 43, Iss 1, Pp 1-10 (2023)
Abstract Background Disease-specific induced pluripotent stem cells (iPSCs) are useful tools for pathological analysis and diagnosis of rare diseases. Given the limited available resources, banking such disease-derived iPSCs and promoting their wides
Externí odkaz:
https://doaj.org/article/4c2420d60fd14b7195ed6fa7be24a185
Autor:
Hideo Saka, Chiyoe Kitagawa, Yukito Ichinose, Mitsuhiro Takenoyama, Hidenori Ibata, Tatsuo Kato, Koji Takami, Motohiro Yamashita, Tadashi Maeda, Sadanori Takeo, Hitoshi Ueda, Kan Okabayashi, Seiji Nagashima, Tadayuki Oka, Hidenori Kouso, Seiichi Fukuyama, Kentaro Yoshimoto, Mototsugu Shimokawa, Akiko M. Saito, Suminobu Ito
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background As the toxicity associated with the α-GalCer-pulsed dendritic cell (DC) therapy could be considered to be negligible, its addition to postoperative adjuvant chemotherapy would be expected to greatly improve the therapeutic effect
Externí odkaz:
https://doaj.org/article/478109fb6b444fdb99397dbffb2a11cf
Autor:
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, Jun Shinga, Takashi Watanabe, Koya Fukunaga, Taisei Mushiroda, Hideo Saka, Chiyoe Kitagawa, Shin-ichiro Shimamatsu, Mitsuhiro Takenoyama, Youko Suehiro, Takumi Imai, Ayumi Shintani, Suminobu Ito, Shin-ichiro Fujii
Publikováno v:
ImmunoHorizons. 7:1-16
NK cells are major effector cells involved in the elimination of early tumors and prevent metastasis. They often have an impaired function in patients with cancer. Preclinical studies have demonstrated NK cell activation as the adjunctive effect of i
Autor:
Suminobu ITO
Publikováno v:
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 27:71-77
Autor:
Toshio Naito, Nao Tsuchida, Susumu Kusunoki, Yoshihiro Kaneko, Morikuni Tobita, Satoshi Hori, Suminobu Ito
This study evaluates the immunogenicity and reactogenicity of BNT162b2 and mRNA-1273 booster doses after the primary two-dose BNT162b2 series in Japan and is the first report from Western Pacific region. Healthcare workers receiving the two-dose BNT1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d409088061754d9fd8e1164893f248
Autor:
Hidenori Matsuo, Hiroshi Sugiyama, Harutoshi Fujimura, Takashi Kawamura, Satoshi Tomita, Hideyuki Sawada, Kwiyoung Park, Masashi Goto, Kosuke Kiyohara, Michikazu Nakamura, Tomoko Oeda, Kenji Yamamoto, Kouichi Mizoguchi, Toshiaki Fukuda, Atsushi Umemura, Kazuko Hasegawa, Seishi Kikuchi, Suminobu Ito, Masayuki Kohsaka
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
ObjectivesBrain acetylcholine is decreased even in patients with cognitively preserved Parkinson’s disease (PD). We investigated whether early and long-term use of donepezil prevents psychosis in non-demented PD patients.MethodsA double-blinded, pl
Autor:
Saka, Hideo, Kitagawa, Chiyoe, Yukito Ichinose, Takenoyama, Mitsuhiro, Ibata, Hidenori, Kato, Tatsuo, Takami, Koji, Yamashita, Motohiro, Maeda, Tadashi, Sadanori Takeo, Ueda, Hitoshi, Okabayashi, Kan, Nagashima, Seiji, Oka, Tadayuki, Kouso, Hidenori, Fukuyama, Seiichi, Yoshimoto, Kentaro, Shimokawa, Mototsugu, Saito, Akiko, Suminobu Ito
SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents*. (DOC 123Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bcd86d8aef52b877618825ef725f7f3
Autor:
Hidenori Ibata, Seiichi Fukuyama, Akiko Saito, Hitoshi Ueda, Kentaro Yoshimoto, Hideo Saka, Tadayuki Oka, Yukito Ichinose, Tadashi Maeda, Mototsugu Shimokawa, Suminobu Ito, Kan Okabayashi, Tatsuo Kato, Seiji Nagashima, Motohiro Yamashita, Chiyoe Kitagawa, Sadanori Takeo, Mitsuhiro Takenoyama, Hidenori Kouso, Koji Takami
Publikováno v:
Trials
Trials, Vol 18, Iss 1, Pp 1-7 (2017)
Trials, Vol 18, Iss 1, Pp 1-7 (2017)
Background As the toxicity associated with the α-GalCer-pulsed dendritic cell (DC) therapy could be considered to be negligible, its addition to postoperative adjuvant chemotherapy would be expected to greatly improve the therapeutic effect, and cou
Autor:
Hideyuki Sawada, Tomoko Oeda, Masayuki Kohsaka, Atsushi Umemura, Satoshi Tomita, Kwiyoung Park, Kouichi Mizoguchi, Hidenori Matsuo, Kazuko Hasegawa, Harutoshi Fujimura, Hiroshi Sugiyama, Michikazu Nakamura, Seishi Kikuchi, Kenji Yamamoto, Toshiaki Fukuda, Suminobu Ito, Masashi Goto, Kosuke Kiyohara, Takashi Kawamura, Sawada, Hideyuki
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry; Dec2018, Vol. 89 Issue 12, p1332-1340, 9p
Autor:
Takefumi Shimizu, Yukihiro Hirao, Takeshi Kawamura, Yoshiharu Inoue, Toshihisa Koga, Suminobu Ito, Jun-Ichi Kunizaki, Makoto Inada, Hitoshi Sato
Publikováno v:
British Journal of Clinical Pharmacology. 60:584-593
Aims Approximately 80% of uracil is excreted as β-alanine, ammonia and CO2 via three sequential reactions. The activity of the first enzyme in this scheme, dihydropyrimidine dehydrogenase (DPD), is reported to be the key determinant of the cytotoxic